Capstone Wealth Management Group (Oregon)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capstone Wealth Management Group (Oregon)'s BMY Position: Q2 2026 in Review
Capstone Wealth Management Group (Oregon) sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7,755 shares — an estimated $470K sold.
Capstone Wealth Management Group (Oregon) first reported a position in BMY in Q4 2024 and held it in 6 quarters. The position peaked at $470K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Capstone Wealth Management Group (Oregon) reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Capstone Wealth Management Group (Oregon) sold 7,755 Bristol-Myers Squibb shares in Q2 2026, an estimated $470K.
- Capstone Wealth Management Group (Oregon) first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 6 quarters.
- Capstone Wealth Management Group (Oregon)'s Bristol-Myers Squibb position peaked at $470K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Capstone Wealth Management Group (Oregon)'s 13F filing for Q2 2026, filed 27 Jul 2026.